Registration & Abstract Submission Guidelines

REGISTRATION ONLY (For those not the presenting author of an abstract)

  • Upon entering the registration page, select guest user; no password is required.
  • Questions? email your questions to


***The deadline for submitting abstracts is March 9th, 2018***

How to submit:

  • ***Before visiting the registration site, first review the abstract instructions &  guidelines below and craft your abstract accordingly. It is not possible to save and return to the abstract submission site.
  • Upon entering the registration page, select guest user; no password is required.
  • At the end of the registration form, if you are the presenting author, follow the link to upload your abstract information. It is important that only the presenting author upload the abstract information to avoid duplicate submissions.
  • Questions? Email your questions to

Please note that when you submit your abstract, you should also take the time to schedule an appointment for designing and/or having a poster printed at the Learning Resource Center (LRC). Appointments fill up fast so schedule early!


The CPRED Program Committee reviews each abstract for its adherence to the guidelines listed below. Please note that a written notification to authors will only be made if an abstract is not accepted.

  1. The body of the abstract cannot be more than 2,000 total characters. This does not include the title, author names, or affiliations. Spaces are not included in the 2,000 count.
  2. The abstract may not contain tables, figures or chemical structures.
  3. Define all nonstandard acronyms.

Abstracts describing the results of experimental studies must answer two questions: “What was done?” and “What was found?” Abstracts must contain the following:

  1. A statement of the rationale and scope of the study presented;
  2. A brief description of the experimental procedures;
  3. The data that resulted from the study; and
  4. Principal conclusion(s) based on interpretation of the results.

Phrases such as “results/data will be discussed” convey no information as to the outcome of the studies and are unacceptable.

All animal experimentation must be carried out in accordance with the University of Texas at Austin’s criteria for the care and use of animals in research.

All abstracts submitted with human testing require that IRB protocol has been followed and approval obtained.

In the case of studies that do not describe laboratory or field experiments, such as reports on educational, ethics, legal, or social initiatives, all the guidelines above apply with the following modifications:

  1. Instead of experimental procedures, the research or assessment approach should be briefly described;
  2. Instead of resultant data, the study’s results or findings should be summarized explicitly; and
  3. These abstracts must clearly articulate the implications for stakeholders.

Abstracts describing new initiatives or science policy in the regulatory community must clearly describe the impact on practice of pharmacy.